Tjandra et al., 2007 - Google Patents
IFN-β signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitorsTjandra et al., 2007
- Document ID
- 17300197712886208120
- Author
- Tjandra S
- Hsu C
- Goh I
- Gurung A
- Poon R
- Nadesan P
- Alman B
- Publication year
- Publication venue
- Cancer research
External Links
Snippet
Aggressive fibromatosis (also called desmoid tumor) is a benign, locally invasive, soft tissue tumor composed of cells with mesenchymal characteristics. These tumors are characterized by increased levels of β-catenin–mediated T-cell factor (TCF)–dependent transcriptional …
- 208000005748 Aggressive Fibromatosis 0 title abstract description 71
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Valle et al. | Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells | |
Rappa et al. | The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma | |
Sadahiro et al. | Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma | |
Lapteva et al. | CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo | |
Zhao et al. | Forced activation of notch in macrophages represses tumor growth by upregulating miR-125a and disabling tumor-associated macrophages | |
Yaddanapudi et al. | Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor | |
Yu et al. | The let-7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD-L1 degradation | |
Li et al. | Low levels of tumor necrosis factor α increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site | |
Uttarkar et al. | Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction | |
Chatterjee et al. | STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90α and β in multiple myeloma cells, which critically contribute to tumor-cell survival | |
Zhang et al. | Synergistic effect of the γ-secretase inhibitor PF-03084014 and docetaxel in breast cancer models | |
Zhang et al. | Hypoxia enhances metastatic efficiency by up-regulating Mdm2 in KHT cells and increasing resistance to apoptosis | |
Saito et al. | Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56 | |
Kochetkova et al. | Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells | |
Marchesi et al. | Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4 | |
Arumugam et al. | S100P promotes pancreatic cancer growth, survival, and invasion | |
Heuser et al. | Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal | |
Fukazawa et al. | Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells | |
Kaneko et al. | Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth | |
Silginer et al. | Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma | |
Carrer et al. | Neuropilin-1 identifies a subset of bone marrow Gr1− monocytes that can induce tumor vessel normalization and inhibit tumor growth | |
Sen et al. | Vα24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement | |
Yang et al. | FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages | |
Sarosiek et al. | Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas | |
Briot et al. | Aberrant activation of stress-response pathways leads to TNF-α oversecretion in Fanconi anemia |